Baclofen can help with certain types of nerve pain, but it is not a first-line treatment for most neuropathic pain conditions. It is FDA-approved specifically for muscle spasticity, so its use for nerve pain is considered off-label. That said, clinical evidence supports its effectiveness for a few specific nerve pain conditions, particularly trigeminal neuralgia and neuropathic pain related to spinal cord injury.
How Baclofen Works on Pain Signals
Baclofen activates a specific receptor in the brain and spinal cord called the GABA-B receptor. GABA is the nervous system’s main “slow down” chemical, and baclofen amplifies that braking effect. It reduces the release of excitatory signaling chemicals from nerve cells while boosting inhibitory signals. The net result is that overactive nerve pathways, the ones firing pain signals when they shouldn’t be, get quieted down.
This mechanism is why baclofen was originally developed for muscle spasticity: it calms the hyperactive nerve circuits that cause muscles to tighten involuntarily. But the same calming effect on nerve signaling is what gives it potential for certain pain conditions where nerves are misfiring.
Where the Evidence Is Strongest
Trigeminal Neuralgia
The best-established use of baclofen for nerve pain is trigeminal neuralgia, a condition that causes sudden, severe jolts of facial pain. In a double-blind study, baclofen significantly reduced the number of painful episodes in 7 out of 10 patients. A larger open trial of 50 patients who had either failed standard medication or couldn’t tolerate it found that 74% experienced relief from their attacks. Some responded to baclofen alone, while others improved when baclofen was combined with previously ineffective doses of other medications. For this condition, baclofen is generally considered a useful second-line option when standard treatments fall short.
Spinal Cord Injury Pain
People with spinal cord injuries often develop neuropathic pain that is difficult to treat. A prospective study of spinal cord injury patients who received baclofen through an implanted pump (intrathecal delivery, which sends the drug directly into the spinal fluid) found significant reductions in neuropathic pain after at least six months of continuous treatment. The improvements were particularly notable for two types of pain: paroxysmal pain (sudden, intense bursts) and dysesthesia (abnormal burning or tingling sensations). Patients also reported that pain interfered less with their daily activities and sleep. Higher doses of baclofen correlated with greater improvements in both pain and sleep quality.
Peripheral Neuropathy
For common peripheral nerve pain conditions like diabetic neuropathy, the evidence for baclofen is limited. One small randomized trial tested a topical gel containing baclofen combined with two other pain-relieving compounds in patients with chemotherapy-induced peripheral neuropathy. The combination gel showed improvements in shooting and burning pain, tingling, and cramping compared to placebo, with no systemic side effects. However, this was a combination product applied to the skin, not oral baclofen taken alone. There is not strong clinical evidence supporting oral baclofen as a standalone treatment for diabetic or other common forms of peripheral neuropathy.
How It Compares to Common Nerve Pain Medications
Gabapentin and pregabalin are the medications most commonly prescribed specifically for nerve pain. No large head-to-head trials have directly compared baclofen to these drugs for neuropathic pain. The closest comparison comes from a study on chronic cough (not nerve pain), where baclofen and gabapentin showed similar effectiveness but baclofen caused notably more side effects: 35% of baclofen patients experienced drowsiness compared to 20.5% on gabapentin, and dizziness occurred in 24% versus 11%.
This side effect profile is one reason baclofen is not typically a first choice for nerve pain. Medications designed specifically for neuropathic pain tend to have a better balance of effectiveness and tolerability for most patients.
Oral Versus Intrathecal Delivery
Baclofen comes in two forms: oral (tablets, liquid, or granules taken by mouth) and intrathecal (delivered directly into the spinal fluid through a surgically implanted pump). Oral baclofen is far more common and is the form most people will encounter. Intrathecal baclofen is typically reserved for severe spasticity and is the form studied for spinal cord injury pain.
The intrathecal route delivers the drug exactly where it needs to act, which means much lower doses can be effective and systemic side effects are reduced. If your provider is discussing baclofen for nerve pain related to a spinal cord condition, they may be referring to the intrathecal form rather than pills.
Typical Dosing
Oral baclofen starts low and increases gradually. The usual starting dose is 5 mg taken three times a day. Every three days, the dose can be increased by 5 mg as needed. The maximum is typically 80 mg per day, split into multiple doses. This slow titration helps your body adjust and minimizes side effects. Most people find their effective dose somewhere in this range over the course of a few weeks.
Side Effects to Expect
The most common side effects of baclofen are drowsiness, dizziness, and muscle weakness. These tend to be more pronounced at higher doses and often improve as your body adjusts. Some people also experience confusion or sedation, especially older adults. At typical prescribed doses, these effects are usually manageable, but they can limit how much of the drug you can tolerate.
At high doses or in cases of overdose, baclofen can cause more serious neurological effects including severely depressed consciousness, seizures, and dangerously low muscle tone. These serious reactions are uncommon at standard doses but are important to be aware of.
Why You Should Never Stop Abruptly
One of the most important things to know about baclofen is that stopping it suddenly can be dangerous. Abrupt discontinuation can trigger a withdrawal syndrome within hours to days, with symptoms including worsening muscle spasms, fever, nausea, anxiety, hallucinations, confusion, and seizures. In rare cases involving intrathecal baclofen, withdrawal has progressed to organ failure and death within one to three days.
Even with oral baclofen, sudden stops or significant dose reductions can cause altered mental status, fever, and autonomic instability (wild swings in heart rate and blood pressure). If you need to stop taking baclofen, the dose should always be tapered gradually. Patients on intrathecal pumps need to be especially vigilant about keeping refill appointments and monitoring for pump malfunctions, since these are common triggers of unintentional withdrawal.
Who Might Benefit
Baclofen is most likely to help with nerve pain if you have trigeminal neuralgia that hasn’t responded well to standard medications, or if you have a spinal cord injury causing both spasticity and neuropathic pain. In the spinal cord injury scenario, a single treatment can address both problems simultaneously, which is a meaningful advantage. For general peripheral neuropathy, baclofen is not a go-to option, and your provider would typically try other medications first. If baclofen is being considered for your nerve pain, it is likely because more conventional options have been tried or because your pain condition overlaps with spasticity.